In the wake of the increase in Current Liabilities in the second quarter 2026, Quick Ratio fell to 4.75 above Standard Biotools Inc average.

Within Laboratory Analytical Instruments industry 3 other companies have achieved higher Quick Ratio than Standard Biotools Inc in second quarter 2026. While Quick Ratio total ranking in the second quarter 2026 has deteriorated compared to the prior quarter from 309 to 727.

Explain Quick Ratio?
How much Cash & cash equivalents LAB�s has?
What are LAB�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

LAB Quick Ratio	(Jun 30 2026) Q2	(Mar 31 2026) Q1	(Dec 31 2025) Q4	(Sep 30 2025) Q3	(Jun 30 2025) Q2
Y / Y Current Liabilities Change	-42.05 %	-24.95 %	123.76 %	-10.49 %	-20.83 %
Y / Y Cash & cash equivalent Change	13.89 %	76.38 %	-35.95 %	-46.8 %	-39.93 %
Quick Ratio MRQ	4.75	10.79	1.7	1.81	2.42
LAB's Total Ranking	# 727	# 309	# 1255	# 1021	# 803
Seq. Current Liabilities Change	34.59 %	-61.79 %	2.29 %	10.14 %	74.31 %
Seq. Cash & cash equivalent Change	-40.68 %	142.66 %	-3.76 %	-17.79 %	-8.13 %

Quick Ratio second quarter 2026 Company Ranking
Within:	No.
Laboratory Analytical Instruments Industry	# 4
Healthcare Sector	# 312
Overall Market	# 727

Quick Ratio Statistics
High	Average	Low
10.79	2.99	0.33
(Mar 31 2026)		(Dec 31 2010)

Financial Statements
Standard Biotools Inc 's Current Liabilities	$ 57 Millions	Visit LAB's Balance sheet
Standard Biotools Inc 's Cash & cash equivalent	$ 270 Millions	Visit LAB's Balance sheet
Source of LAB's Sales		Visit LAB's Sales by Geography

Cumulative Standard Biotools Inc 's Quick Ratio

LAB's Quick Ratio for the trailling 12 Months

LAB Quick Ratio	(Jun 30 2026) 12 Months	(Mar 31 2026) 12 Months	(Dec 31 2025) 12 Months	(Sep 30 2025) 12 Months	(Jun 30 2025) 12 Months
Y / Y Current Liabilities TTM Growth	-2.1 %	2.46 %	-10.27 %	-35.39 %	-21.57 %
Y / Y Cash & cash equivalent TTM Growth	-4.04 %	-18.08 %	-42.12 %	-26.55 %	4.87 %
Quick Ratio TTM	3.49	3	2.35	3.15	3.56
Total Ranking TTM	# 3768	# 2992	# 2911	# 3027	# 2324
Seq. Current Liabilities TTM Growth	-11.49 %	-3.77 %	19.6 %	-3.9 %	-7.37 %
Seq. Cash & cash equivalent TTM Growth	3.07 %	22.46 %	-10.71 %	-14.85 %	-12.01 %

Quick ratio ranking by company, industry and sector >> Back to LAB Financial Strength Comparisons >> Go to Compare LAB Quick Ratio to its Competitors

On the trailing twelve months basis LAB Cash & cash equivalent increased by 13.89 % in Q2 2026 year on year, while Current Liabilities grew to $57 millions, this led to increase in in Standard Biotools Inc 's Quick Ratio to 3.49, above LAB average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Laboratory Analytical Instruments industry 21 other companies have achieved higher Quick Ratio than Standard Biotools Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2026 from 2992 to 3768.

Explain Quick Ratio?
How much Cash & cash equivalents LAB�s has?
What are LAB�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Laboratory Analytical Instruments Industry	# 22
Healthcare Sector	# 871
Within the Market	# 3768

trailing twelve months Quick Ratio Statistics
High	Average	Low
6.39	2.81	0.6
(Jun 30 2013)		(Mar 31 2022)

Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Laboratory Analytical Instruments Industry	Quick Ratio	Jun 30 2026 MRQ Cash & cash equivalent	Jun 30 2026 MRQ Current Liabilities
Alamar Biosciences Inc	8.94	$ 250.052 Millions	$ 27.960 Millions
Eyepoint Inc	7.80	$ 327.214 Millions	$ 41.943 Millions
Astrotech Corp	5.02	$ 11.334 Millions	$ 2.257 Millions
Scientific Industries Inc	4.92	$ 7.882 Millions	$ 1.602 Millions
Standard Biotools Inc	4.75	$ 270.026 Millions	$ 56.802 Millions
10x Genomics Inc	4.66	$ 552.058 Millions	$ 118.509 Millions
Pacific Biosciences Of California Inc	3.44	$ 236.873 Millions	$ 68.806 Millions
Cytek Biosciences Inc	2.83	$ 262.004 Millions	$ 92.698 Millions
Quanterix Corporation	1.86	$ 93.529 Millions	$ 50.373 Millions
Nautilus Biotechnology Inc	1.52	$ 13.166 Millions	$ 8.639 Millions
Rapid Micro Biosystems Inc	1.13	$ 20.500 Millions	$ 18.150 Millions
Bionano Genomics Inc	1.04	$ 10.420 Millions	$ 10.039 Millions

Date modified: 2026-09-01T20:00:47+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.